Stock listing

A423J5 Stock Price, News, Filings & Events — Harvard Bioscience, Inc.

Selected listing: A423J5 · LSX · EUR · DE

This page tracks Harvard Bioscience, Inc.'s A423J5:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A423J5:LSX. A423J5:LSX is the stock-level entry point for investors researching Harvard Bioscience, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Harvard Bioscience, Inc. (Ticker: HBIO) is a public company based in America, specializing in the development and manufacturing of innovative tools and equipment for life science research. With a market capitalization of approximately $27 million, the company focuses on providing high-quality products that support scientific advancements in various fields.

A423J5:LSXEURDEUpdated August 28, 2026
Harvard Bioscience, Inc. logo
Ticker
A423J5:LSX
Asset type
Stock
Market cap
$36.1M
Sector
Health Technology
Industry
Medical Specialties
Exchange
LSX
Currency
EUR

Harvard Bioscience, Inc. A423J5:LSX stock context

This page tracks Harvard Bioscience, Inc.'s A423J5:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A423J5:LSX. A423J5:LSX is the stock-level entry point for investors researching Harvard Bioscience, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Harvard Bioscience, Inc. (Ticker: HBIO) is a public company based in America, specializing in the development and manufacturing of innovative tools and equipment for life science research. With a market capitalization of approximately $27 million, the company focuses on providing high-quality products that support scientific advancements in various fields.

Latest news from Harvard Bioscience, Inc.

All Harvard Bioscience, Inc. news →

Harvard Bioscience, Inc. earnings calls

Research Harvard Bioscience, Inc.

Alternate listings